Keep Up With Global Black News

Sign up to our newsletter to get the latest updates and events from the leading Afro-Diaspora publisher straight to your inbox.

BY Azuka onye, 12:00am October 19, 2011,

Another Reason to Quit: Thromboangiitis Obliterans

by Azuka onye, 12:00am October 19, 2011,

Thromboangiitis Obliterans, commonly referred to as Bueger’s disease, is a disease involving the blood vessels in the hands and feet. People with TO experience progressive bouts of inflammation and clotting in the small and medium arteries and veins. The biggest culprit for this disease is smoking.

Because of the poor circulation through their blood vessels, those with TO may present with ulcers and/or gangrene in certain areas of their hands and feet. Without intervention the gangrenous extremities are eventually amputated.

Another Reason to Quit: Thromboangiitis Obliterans

TO is a rare disease, however, it is commonly found amongst those who smoke or use Tobacco. Researchers believe that TO is an autoimmune disease and that something in the tobacco may trigger the inflammatory process.

There is no cure for the disease and treatment is mostly supportive. Patients are encouraged to stop smoking in order to slow the progression of the TO but it does not stop its progression. The best way to avoid it is to not smoke at all. If you do smoke quit now. It is never too late. Below are the signs and symptoms associated with TO.

  •  Blue, red or pale hands and feet
  •  Pain, burning or tingling in the hands and feet
  •  Hands and feet abnormally cold
  •  Pain in the lower extremities when walking
  •  Dark discoloration or ulcerations of the hands and feet

For more information about how to quit smoking please visit: http://www.smokefree.gov
 

Last Edited by: Updated: February 25, 2014

Conversations

Must Read

Connect with us

Join our Mailing List to Receive Updates

Face2face Africa | Afrobeatz+ | BlackStars

Keep Up With Global Black News and Events

Sign up to our newsletter to get the latest updates and events from the leading Afro-Diaspora publisher straight to your inbox, plus our curated weekly brief with top stories across our platforms.

No, Thank You